86 related articles for article (PubMed ID: 38532463)
21. SOX2 contributes to invasion and poor prognosis of gastric cancer: A meta-analysis.
Tang K; Liu J; Liu B; Meng C; Liao J
Medicine (Baltimore); 2022 Sep; 101(36):e30559. PubMed ID: 36086709
[TBL] [Abstract][Full Text] [Related]
22. ORAI1 regulates sustained cytosolic free calcium fluctuations during breast cancer cell apoptosis and apoptotic resistance via a STIM1 independent pathway.
Bassett JJ; Robitaille M; Peters AA; Bong AHL; Taing MW; Wood IA; Sadras F; Roberts-Thomson SJ; Monteith GR
FASEB J; 2022 Jan; 36(1):e22108. PubMed ID: 34939697
[TBL] [Abstract][Full Text] [Related]
23. Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma.
Paterson C; Kilmister EJ; Brasch HD; Bockett N; Patel J; Paterson E; Purdie G; Galvin S; Davis PF; Itinteang T; Tan ST
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685477
[TBL] [Abstract][Full Text] [Related]
24. SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.
Hosseini-Khah Z; Babaei MR; Tehrani M; Cucchiarini M; Madry H; Ajami A; Rakhshani N; Rafiei A; Nikbin B
Curr Oncol; 2021 Aug; 28(4):3015-3029. PubMed ID: 34436030
[TBL] [Abstract][Full Text] [Related]
25. [Surgery for periampullary pancreatic cancer].
Hank T; Klaiber U; Sahora K; Schindl M; Strobel O
Chirurg; 2021 Sep; 92(9):776-787. PubMed ID: 34259884
[TBL] [Abstract][Full Text] [Related]
26. ORAI3 contributes to hypoxia-inducible factor 1/2α-sensitive colon cell migration.
Zhu D; He R; Yu W; Li C; Cheng H; Zhu B; Yan J
Physiol Int; 2021 Jun; ():. PubMed ID: 34161303
[TBL] [Abstract][Full Text] [Related]
27. Development of Store-Operated Calcium Entry-Targeted Compounds in Cancer.
Liang X; Zhang N; Pan H; Xie J; Han W
Front Pharmacol; 2021; 12():688244. PubMed ID: 34122115
[TBL] [Abstract][Full Text] [Related]
28. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
[TBL] [Abstract][Full Text] [Related]
29. Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.
Kasashima H; Duran A; Martinez-Ordoñez A; Nakanishi Y; Kinoshita H; Linares JF; Reina-Campos M; Kudo Y; L'Hermitte A; Yashiro M; Ohira M; Bao F; Tauriello DVF; Batlle E; Diaz-Meco MT; Moscat J
Dev Cell; 2021 Jan; 56(1):95-110.e10. PubMed ID: 33207226
[TBL] [Abstract][Full Text] [Related]
30. Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer.
Bulle A; Lim KH
Signal Transduct Target Ther; 2020 Oct; 5(1):249. PubMed ID: 33122631
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of SOX2 as an anticancer target.
Zhang S; Xiong X; Sun Y
Signal Transduct Target Ther; 2020 Jul; 5(1):135. PubMed ID: 32728033
[TBL] [Abstract][Full Text] [Related]
32. STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma.
Zhao H; Yan G; Zheng L; Zhou Y; Sheng H; Wu L; Zhang Q; Lei J; Zhang J; Xin R; Jiang L; Zhang X; Chen Y; Wang J; Xu Y; Li D; Li Y
Theranostics; 2020; 10(14):6483-6499. PubMed ID: 32483465
[No Abstract] [Full Text] [Related]
33. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
[TBL] [Abstract][Full Text] [Related]
34. Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca
Huang HK; Lin YH; Chang HA; Lai YS; Chen YC; Huang SC; Chou CY; Chiu WT
J Biomed Sci; 2020 Feb; 27(1):36. PubMed ID: 32079527
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological Implication of Long Non-Coding RNAs SOX2 Overlapping Transcript and Its Potential Target Gene Network in Various Cancers.
Li Y; Du M; Wang S; Zha J; Lei P; Wang X; Wu D; Zhang J; Chen D; Huang D; Lu J; Li H; Sun M
Front Genet; 2019; 10():1375. PubMed ID: 32038720
[TBL] [Abstract][Full Text] [Related]
36. Immune Functional Analysis of
Yu HZ; Li NY; Li B; Toufeeq S; Xie YX; Huang YL; Du YM; Zeng XD; Zhu B; Lu ZJ
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861829
[TBL] [Abstract][Full Text] [Related]
37. Stromal interaction molecule 1 promotes tumor growth in Esophageal squamous cell carcinoma.
Tang J; Ye S; Wang M; Li J; Meng X; Liu F
Genomics; 2020 May; 112(3):2146-2153. PubMed ID: 31843504
[TBL] [Abstract][Full Text] [Related]
38. Targeting oncogenic SOX2 in human cancer cells: therapeutic application.
Zhang S; Sun Y
Protein Cell; 2020 Feb; 11(2):82-84. PubMed ID: 31748974
[No Abstract] [Full Text] [Related]
39. Chemoresistance in Pancreatic Cancer.
Zeng S; Pöttler M; Lan B; Grützmann R; Pilarsky C; Yang H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514451
[TBL] [Abstract][Full Text] [Related]
40. The 2019 WHO classification of tumours of the digestive system.
Nagtegaal ID; Odze RD; Klimstra D; Paradis V; Rugge M; Schirmacher P; Washington KM; Carneiro F; Cree IA;
Histopathology; 2020 Jan; 76(2):182-188. PubMed ID: 31433515
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]